Ignore this cluster, the dollar amounts are trivial relative to market cap and consistent with routine portfolio diversification. No insider buying to offset the sales. Monitor upcoming Phase 2/3 readouts for the real catalysts; insider trading patterns here are noise.
DNLI drugs
DNLI drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 10 $21.40entry
- T+1 · 2mo ago −1.45%α −2.30% · $21.09
- T+5 · 2mo ago −5.93%α −6.56% · $20.13
- T+20 · 6w ago −12.76%α −15.14% · $18.67
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Denali insiders (COFO, Director, CMO) sold a total of ~$349K in open-market sales over a 5-day window. The aggregate dollar value is ~0.01% of the $3.5B market cap, well below the 0.1% materiality threshold. These are routine, small-dollar sales by a mix of C-suite and board members, no single insider sold more than $250K. The cluster carries no informational signal and does not change the fundamental outlook for the stock.
Key Financial Metrics
Key Facts
- Three insiders sold shares totaling ~$349K over 5 days
- Total sales represent ~0.01% of $3.5B market cap, trivial
- Sales were open-market (code S), not tax-withholding or derivative exercises
- Largest single sale was Director Thornberry's $247K; COFO Schuth sold $65K; CMO Chin sold $37K
- No insider bought shares in the cluster window
Financial Impact
~$349K in insider sales, ~0.01% of market cap, immaterial
Risk Factors
- Small insider sales could precede a broader sell-off if negative data emerges, but the amounts here are too small to signal informed selling
- No insider buying to signal conviction ahead of catalysts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DNLI-1789027737969 |
Track record
17 reports on DNLI
3 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +23.19% at T+60 after the May 7, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.75 Now $18.08 −3.55% settles Nov 17
- Nov 3, 202613d ago 8-K Bullish 6/10 No price data
- Nov 3, 202613d ago Press Release Neutral 5/10 Entry $20.96 to $19.72 Now $18.08 −13.74% ▼ −5.92% −1.51% vs SPY
- Oct 30, 202617d ago Press Release Neutral 3/10 Entry $18.94 to $18.86 Now $18.08 −4.54% ▼ −0.42% +0.06% vs SPY
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $18.66 Now $18.08 −3.11% No price data
- Sep 9, 20269w ago Insider Cluster Neutral 2/10 Viewing Entry $21.40 to $21.09 Now $18.08 −15.51% ▼ −1.45% −2.30% vs SPY
- Sep 4, 202610w ago Insider Cluster Neutral 2/10 Entry $22.08 to $21.57 Now $18.08 −18.12% ▼ −2.31% −1.84% vs SPY
- Aug 6, 202614w ago 8-K Mixed 6/10 Entry $24.83 to $25.00 Now $18.08 −27.18% ▲ +0.68% +0.71% vs SPY
- Jul 27, 202616w ago Press Release Neutral 1/10 Entry $24.05 Now $18.08 −24.82% No price data
- Jun 18, 202621w ago 8-K Bullish 6/10 Entry $23.31 to $24.05 Now $18.08 −22.44% ▲ +3.17% +3.49% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers